US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms

ARS Pharmaceuticals

05/03/2025 21:14

March 5 (Reuters) - The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' SPRY.O nasal spray for severe allergic reactions in patients who weigh between 15 to 30 kilograms, the company said on Wednesday.

 (Reporting by Christy Santhosh and Puyaan Singh in Bengaluru; Editing by Shailesh Kuber and Alan Barona)

 ((Christy.Santhosh@thomsonreuters.com))